This inventor holds 1 USPTO granted patent. Top assignees: Unversität Zürich, Wayne State University. Active years: 2022.
Company Filing History:
1 out of 276 
1 out of 602 
Years Active: 2022
Title: Appi Reddy Mandhapati: Innovator in Antibacterial Drug Development
Introduction
Appi Reddy Mandhapati is a notable inventor based in Detroit, MI (US). He has made significant contributions to the field of antibacterial drugs, particularly through his innovative work on neomycin and paromomycin derivatives. His research focuses on enhancing the efficacy of aminoglycoside antibacterial drugs.
Latest Patents
Mandhapati holds a patent for "Neomycin and paromomycin derivatives." This patent relates to derivatives of neamine-based aminoglycoside antibacterial drugs that are modified at positions C6', C2', and/or C5''. These modifications provide favorable properties regarding activity against ESKAPE pathogens, evasion of resistance traits, and increased selectivity, enabling systemic use of the compounds. He has 1 patent to his name.
Career Highlights
Throughout his career, Mandhapati has worked with prestigious institutions such as Wayne State University and Universität Zürich. His research has contributed to advancements in the field of antibacterial treatments, showcasing his commitment to improving public health.
Collaborations
Mandhapati has collaborated with esteemed colleagues, including David Crich and Girish Sati. These partnerships have further enriched his research and development efforts in the field of medicinal chemistry.
Conclusion
Appi Reddy Mandhapati is a distinguished inventor whose work on neomycin and paromomycin derivatives has the potential to significantly impact the treatment of bacterial infections. His contributions to antibacterial drug development highlight the importance of innovation in addressing public health challenges.